Liver and pregnancy;Foie et grossesse

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 5 SUPPL., 2004, Pages

  Chazouillères, Olivier ^a   Bacq, Yannick ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLDOPA; PHENOTHIAZINE DERIVATIVE;

ACUTE DISEASE; AUTOIMMUNE DISEASE; BUDD CHIARI SYNDROME; CHOLELITHIASIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DRUG INDUCED DISEASE; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTENSION; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; LIVER FATTY DEGENERATION; LIVER TOXICITY; PREECLAMPSIA; PREGNANCY; TOXIC HEPATITIS; URINARY TRACT INFECTION; VIRUS HEPATITIS; VOMITING;

FEMALE; HUMANS; LIVER; LIVER DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; URINARY TRACT INFECTIONS;

EID: 3042633530     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Bacq Y, Zarka O. Le foie au cours de la grossesse normale. Gastroenterol Clin Biol 1994;18:767-74.
2. Bacq Y, Zarka O, Brechot J-F, Mariotte N, Vol S, Tichet J, et al. Liver Function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996;23:1030-4.
3. Harris GJ, Al-Jurf AS, Yuh WTC, Abu-Yousef MM. Intrahepatic pregnancy. A unique opportunity for evaluation with sonography, computed tomography, and magnetic resonance imaging. JAMA 1989;261:902-4.
4. Abell TL, Riely CA. Hyperemesis gravidarum. Gastroenterol Clin North Am 1992;21:835-49.
5. Riely CA. Practice guidelines. Liver disease in the pregnant patient. Am J Gastroenterol 1999;94:1728-32.
6. Safari HR, Fassett MJ, Souter IC, Alsulyman OM, Goodwin TM. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol 1998;179:921-4.
7. Bacq Y. La stéatose hépatique aiguë gravidique. Gastroenterol Clin Biol 1997;21:109-15.
8. Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999;181:389-95.
9. Reyes H, Sandoval L, Wainstein A, Ribalta J, Donoso S, Smok G, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 1994;35:101-6.
10. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876-80.
11. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy. A clinicopathologic study of 35 cases. Hepatology 1985;5:1149-58.
12. Bernuau J, Degott C, Nouel O, Rueff B, Benhamou JP. Non-fatal acute fatty liver of pregnancy. Gut 1983;24:340-4.
13. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. Hepatology 1994;19:339-45.
14. Sims H, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, et al. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci 1995;92:841-5.
15. Ibdah JA, Bennet MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-31.
16. Mansouri A, Fromenty B, Durand F, Degott C, Bernuau J, Pessayre D. Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy. J Hepatol 1996;25:781.
17. Maitra A, Domiati-Saad R, Yost N, Cunningham G, Rogers BB, Bennett MJ. Absence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy. Pediatr Res 2002;51:658-61.
18. Ibdah JA, Yang ZY, Bennet MJ. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 2000;71:182-9.
19. Rolfes DB, Ishak KG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986;81:1138-44.
20. Saphier CJ, Repke JT. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management. Semin Perinatol 1998;22:118-33.
21. Curtis WM, Weinstein L. A review of HELLP syndrome. J Perinatol 1999;9:38-43.
22. Pottecher T. Réanimation des formes graves de pré- éclampsie (texte court). J Gynecol Obstet Biol Reprod 2001;30:121-32.
23. Costentin L, Zafrani E-S, Dhumeaux D, Mallat A. Constitution rapide de calcifications intra-hépatiques au décours d'un syndrome HELLP. Gastroenterol Clin Biol 2002;26:802-3.
24. Ralston SJ, Schwaitzberg SD. Liver hematoma and rupture in pregnancy. Semin Perinatol 1998;22:141-8.
25. Bacq Y, Riely CA. Acute fatty liver of pregnancy: the hepatologist's view. The Gastroenterologist 1993;1:257-64.
26. Bacq Y, Sapey T. Cholestase intrahépatique gravidique. Gastroenterol Clin Biol 1998;22:705-13.
27. Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F. Intrahepatic Hépathopaties of pregnancy: a French prospective study. Hepatology 1997;26:358-64.
28. Bacq Y. Hépatopathies au cours de la grossesse. Gastroenterol Clin Biol 2001;25:791-8.
29. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
30. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001;120:1459-67.
31. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353:210-1.
32. Lucena JF, Herrero JI, Quiroga J, Sangro B, Garcia-Foncillas J, Zabalegui N, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003;124:1037-42.
33. Dixon PH, Weerasekera N, Linton KJ, Donalson O, Chambers J, Egginton E, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000;9:1209-17.
34. Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003;40:32.
35. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993;13:289-301.
36. Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000;32:94-106.
37. Benifla JL, Dumont M, Levardon M, Foucher E, Cadiot G, Crenn-Hebert C, et al. Effets de la progestérone naturelle micronisée sur le foie au cours du troisième trimestre de la grossesse. Contracept Fertil Sex 1997;25:165-9.
38. Reyes H, Baez ME, Gonzales MC, Hernandez I, Palma J, Ribalta J, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000;32:542-9.
39. Estève E. Conduite à tenir devant un prurit de la femme enceinte. Ann Dermatol Venereol 1999;126:634-8.
40. Kenyon AP, Nelson Piercy C, Girling J, Williamson C, Tribe RM, Shennan AH. Pruritus may precede abnormal liver function tests in pregnant women obstetric cholestasis: a longitudinal analysis. Br J Obstet Gynecol 2001;108:1190-2.
41. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997;27:1022-8.
42. Rodrigues CMP, Marin JJG, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not not altered by ursodeoxycholic acid treatment. Gut 1999;45:446-52.
43. Mazzella G, Nicola R, Francesco A, Patrizia S, Luciano B, Anna M, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001;33:504-8.
44. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999;94:189-93.
45. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994;170:890-5.
46. Steinbrook RA, Broocks DC, Datta S. Laparoscopic cholecystectomy during pregnancy. Surg Endosc 1996;10:511-5.
47. Hussaini SH, Skidmore SJ, Richardson P. Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hep 1997;4:51-4.
48. Klein NA, Mabie WC, Shaver DC, Latham PS, Adamec TA, Pinstein ML, et al. Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 1991;100:239-4.
49. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: Lessons from Chile. Hepatology 1982;2:87-96.
50. Picaud A, Walter P, de Préville G, Nicolas P. Hépatite toxique mortelle au cours de la grossesse. Discussion du rôle de la méthyldopa. J Gynecol Obstet Biol Reprod 1990;19:192-6.
51. Lewis JH. Drug hepatotoxicity in pregnancy. Eur J Gastroenterol Hepatol 1991;3:883-91.
52. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980;68:113-21.
53. Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001;48:97-102.
54. Sternlieb I. Wilson's disease and pregnancy. Hepatology 2000;31:531-2.
55. Ville Y, Fernandez H, Samuel D, Bismuth H, Frydman R. Pregnancy in liver transplant recipients: Course and outcome in 19 cases. Am J Obstet Gynecol 1993;168:896-902.
56. Armenti VT, Herrine SK, Radomski JS, Moritz MJ. Pregnancy after liver transplantation. Liver Transpl 2000;6:671-85.
57. Locatelli A, Roncaglia N, Arreghini A, Bellini P, Vergani P, Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999;106:498-500.
58. Conte D, Fraquelli M, Prati D, Coluci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000;31:751-5.
59. Gervais A, Bacq Y, Bemuau J, Martinot M, Auperin A, Boyer N, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000;32:293-9.
60. Grangé JD, Antoine JM, Amiot X. Virus de l'hépatite C et grossesse. Gastroenterol Clin Biol 1999;23:1033-9.
61. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999;31(suppl. 1):3-7.
62. Chazouillères O, Poupon R, Bonnand AM, Poupon RE. Pregnancy and ursodeoxycholic acid (UDCA) treatment induce remission of primary biliary cirrhosis (PBC). Hepatology 1998;28:545A.
63. Janczewska I, Olsson R, Hultcrantz R, Broomé U. Pregnancy in patients with primary sclerosing cholangitis. Liver 1996;16:326-30.